Astera Labs (NASDAQ:ALAB) Director Stefan Dyckerhoff Sells 8,994 Shares

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $200.03, for a total transaction of $1,799,069.82. Following the completion of the transaction, the director directly owned 5,953 shares in the company, valued at approximately $1,190,778.59. The trade was a 60.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Price Performance

Shares of Astera Labs stock traded up $7.56 on Monday, hitting $207.35. 5,600,886 shares of the company’s stock traded hands, compared to its average volume of 6,128,509. The firm’s 50-day moving average price is $143.77 and its two-hundred day moving average price is $153.99. The stock has a market capitalization of $35.54 billion, a PE ratio of 147.99, a price-to-earnings-growth ratio of 3.30 and a beta of 3.35. Astera Labs, Inc. has a one year low of $76.53 and a one year high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts forecast that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Astera Labs

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Astera Labs by 14.1% during the 3rd quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares in the last quarter. Atreides Management LP raised its holdings in Astera Labs by 2,496.6% during the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after buying an additional 1,549,144 shares during the period. Amundi lifted its stake in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC acquired a new position in shares of Astera Labs in the third quarter valued at approximately $209,599,000. Finally, BNP Paribas Financial Markets boosted its holdings in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after buying an additional 960,899 shares during the period. Institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on ALAB shares. Morgan Stanley upped their price target on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Loop Capital started coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price for the company. Susquehanna increased their target price on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a report on Wednesday, May 6th. Finally, Roth Mkm reissued a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average target price of $229.65.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.